BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ALC01 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ALC01\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07212088-1592@assetmemo.bio
DTSTAMP:20261121T005406Z
DTSTART;VALUE=DATE:20271215
DTEND;VALUE=DATE:20271216
SUMMARY:ALC01: Phase 1 readout est. (NCT07212088)
DESCRIPTION:ALC01\, phase 1\, Parkinson's Disease.\nStudy: Stereotactic Int
 racerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's D
 isease\nEstimated primary completion: 15 December 2027. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/alc01#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07212088
URL:https://assetmemo.bio/drug/alc01#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
